凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06821 凯莱英

未开盘 01-22 16:08:18

84.400

-0.350

-0.41%

最高86.000	最低83.500	成交量10.34万
今开84.750	昨收84.750	日振幅2.95%
总市值304.68亿	流通市值23.25亿	总股本3.61亿
成交额870.75万	换手率0.38%	流通股本2,755万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":84.4,"timestamp":1769069298005,"preClose":84.75,"halted":0,"volume":103400,"delay":0,"changeRate":-0.004129793510324417,"floatShares":27553260,"shares":361000000,"eps":2.69,"marketStatus":"未开盘","change":-0.35,"latestTime":"01-22 16:08:18","open":84.75,"high":86,"low":83.5,"amount":8707455,"amplitude":0.029499,"askPrice":84.45,"askSize":200,"bidPrice":84,"bidSize":300,"shortable":3,"etf":0,"ttmEps":3.127486,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769131800000},"marketStatusCode":0,"adr":0,"listingDate":1639065600000,"exchange":"SEHK","adjPreClose":84.75,"dividendRate":0.014603,"openAndCloseTimeList":[[1769045400000,1769054400000],[1769058000000,1769068800000]],"volumeRatio":0.3607105927148339,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":102.86,"timestamp":1769065200000,"preClose":103.8,"halted":0,"volume":2649300,"delay":0,"premium":"-26.71"}},"requestUrl":"/m/hq/s/06821","defaultTab":"news","newsList":[{"id":"2605390644","title":"谭冬寒2025年四季度表现，工银领航三年持有混合基金季度跌幅5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605390644","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605390644?lang=zh_cn&edition=full","pubTime":"2026-01-22 07:13","pubTimestamp":1769037223,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2025年四季度末，基金经理谭冬寒旗下共管理9只基金，本季度表现最佳的为工银领航三年持有混合，季度净值跌5.02%。持有期间的估算收益率为94.05%，持有期间博腾股份在2021年到2022年的年报归属净利润增幅达282.78%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200004373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2605849344","title":"股市必读：凯莱英（002821）1月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605849344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605849344?lang=zh_cn&edition=full","pubTime":"2026-01-22 01:29","pubTimestamp":1769016548,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，凯莱英报收于103.8元，上涨0.58%，换手率1.23%，成交量3.91万手，成交额4.09亿元。董秘最新回复投资者： 贵司小分子PPQ项目的减少，是否意味着小分子商业化项目的减少？当日关注点来自交易信息汇总：1月21日主力资金净流入1747.64万元，呈现明显吸筹迹象。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200000610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","06821","BK1191","LU1328615791.USD","002821","BK0239"],"gpt_icon":0},{"id":"2605776921","title":"每日卖空追踪 | 凯莱英 01月21日卖空量成交900股，卖空比例为0.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605776921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605776921?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:30","pubTimestamp":1768984240,"startTime":"0","endTime":"0","summary":"凯莱英北京时间01月21日，涨0.89%，卖空量成交900股，较上一交易日减少95.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165756a444d7d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165756a444d7d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2604013818","title":"Norges Bank减持凯莱英(06821)11万股 每股作价约88.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604013818","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604013818?lang=zh_cn&edition=full","pubTime":"2026-01-19 19:08","pubTimestamp":1768820899,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，1月14日，Norges Bank减持凯莱英(06821)11万股，每股作价88.1971港元，总金额约为970.17万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20260119/20260119190838_98807.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260119/20260119190838_98807.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0239","002821","BK1191","06821","BK0132","LU1328615791.USD"],"gpt_icon":0},{"id":"2604597901","title":"股市必读：凯莱英（002821）1月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604597901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604597901?lang=zh_cn&edition=full","pubTime":"2026-01-19 01:28","pubTimestamp":1768757289,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，凯莱英报收于107.33元，上涨0.78%，换手率1.88%，成交量5.97万手，成交额6.39亿元。公司所服务的PPQ项目数量会随着公司所服务的项目进展，比如获批上市等情况动态变化。当日关注点来自交易信息汇总：1月16日主力资金净流出4067.55万元，游资资金净流入4069.08万元，呈现主力与游资反向操作态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900000525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","BK0132","BK0239","LU1328615791.USD","BK1191","002821"],"gpt_icon":0},{"id":"2603587965","title":"凯莱英01月16日主力净流出209.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2603587965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603587965?lang=zh_cn&edition=full","pubTime":"2026-01-16 16:15","pubTimestamp":1768551325,"startTime":"0","endTime":"0","summary":"01月16日, 凯莱英股价跌1.73%，报收88.15元，成交金额2221.4万元，换手率0.91%，振幅3.01%，量比0.34。凯莱英今日主力资金净流出209.3万元，上一交易日主力净流入165.5万元。该股近5个交易日上涨3.34%，主力资金累计净流出44.4万元；近20日主力资金累计净流入1909.0万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116161707a4cb214e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116161707a4cb214e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2603954830","title":"一哥”3年砸100亿圈地，千亿市场正在“变天","url":"https://stock-news.laohu8.com/highlight/detail?id=2603954830","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603954830?lang=zh_cn&edition=full","pubTime":"2026-01-16 09:49","pubTimestamp":1768528160,"startTime":"0","endTime":"0","summary":"这一收购价较东曜药业2025年12月22日收盘价溢价99%，较过去30个交易日平均收盘价更是溢价114.67%。其二，强化市场地位。从“拼价格”到“拼体系”中国的ADC CDMO，正在“变身”。皓元医药2025年前三季度前端业务营收14.5亿元，同比增长31%，后端业务营收6亿元，同比增长16.9%。其承接的XDC项目超70个，截至2025年6月，在22家ADC出海的国内公司中，服务了95%以上出","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116095150a4c9c462&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116095150a4c9c462&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1191","SG9999014674.SGD","06821","BK1141","02268","01875"],"gpt_icon":0},{"id":"2603965307","title":"每日卖空追踪 | 凯莱英 01月15日卖空量成交1.06万股，卖空比例为1.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603965307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603965307?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:30","pubTimestamp":1768465838,"startTime":"0","endTime":"0","summary":"凯莱英北京时间01月15日，涨4.18%，卖空量成交1.06万股，较上一交易日减少75.8%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164308a4c6d644&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164308a4c6d644&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2603612307","title":"每日卖空追踪 | 凯莱英 01月14日卖空量成交5600股，卖空比例为0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603612307?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:30","pubTimestamp":1768379437,"startTime":"0","endTime":"0","summary":"凯莱英北京时间01月14日，跌2.66%，卖空量成交5600股，较上一交易日减少78.87%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164612a7196f58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114164612a7196f58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2603516612","title":"凯莱英01月14日主力净流出20.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2603516612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603516612?lang=zh_cn&edition=full","pubTime":"2026-01-14 16:15","pubTimestamp":1768378523,"startTime":"0","endTime":"0","summary":"01月14日, 凯莱英股价跌2.66%，报收86.10元，成交金额6400.5万元，换手率2.64%，振幅8.14%，量比0.86。凯莱英今日主力资金净流出20.8万元，上一交易日主力净流入168.6万元。该股近5个交易日上涨2.14%，主力资金累计净流入1165.0万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1977.8万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114161641a7194b09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114161641a7194b09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","06821"],"gpt_icon":0},{"id":"2603688509","title":"Schroders PLC减持凯莱英(06821)16.77万股 每股作价约83.63港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688509","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603688509?lang=zh_cn&edition=full","pubTime":"2026-01-13 18:53","pubTimestamp":1768301597,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，1月9日，Schroders PLC减持凯莱英(06821)16.77万股，每股作价83.6305港元，总金额约为1402.48万港元。减持后最新持股数目为550.56万股，最新持股比例为19.98%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","002821","BK1191","LU1328615791.USD","06821","BK0239"],"gpt_icon":0},{"id":"2603575538","title":"港股异动 | CRO概念股涨幅居前 药明康德(02359)去年净利预计翻倍 板块有望迎“戴维斯双击”","url":"https://stock-news.laohu8.com/highlight/detail?id=2603575538","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603575538?lang=zh_cn&edition=full","pubTime":"2026-01-13 10:09","pubTimestamp":1768270178,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股涨幅居前，截至发稿，药明康德涨8.48%，报120.2港元；凯莱英涨7.4%，报91.4港元；康龙化成涨7.13%，报24.64港元；泰格医药涨7.16%，报53港元；药明生物涨5%，报39.46港元。消息面上，1月12日晚，药明康德公布，公司全年预计实现营业收入454.56亿元，同比增长15.84%；其中，持续经营业务收入同比增长约21.40%。预计经调整归母净利润149.57亿元，同比增长约41.33%；归属于公司股东的净利润191.51亿元，同比增长约 102.65%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d9a285c5d35960016c392e2c485f56f0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0456842615.SGD","BK1610","02359","LU0051755006.USD","LU0708995583.HKD","LU1242518857.USD","LU2125910500.SGD","BK1141","LU0039217434.USD","LU0516422440.USD","LU0417516902.SGD","LU0588546209.SGD","BK0216","LU1046422090.SGD","LU0516423091.SGD","SG9999002463.SGD","06821","LU0456827905.SGD","03759","LU0516422366.SGD","BK1576","BK1583","03347","LU0417516738.SGD","LU1808992512.USD","LU2495084118.USD","LU0348825331.USD","603259","LU1997245177.USD","LU0320764599.SGD","IE00B0JY6N72.USD","LU0572944931.SGD","LU0140636845.USD","LU1934453819.USD","LU1997244956.HKD","LU0823426308.USD","LU0456846285.SGD","LU1720050803.USD","LU2039709279.SGD","LU0181495838.USD","LU1997245094.SGD","LU1794554557.SGD","LU0819121731.USD","LU0052750758.USD","LU2045819591.USD","LU0359201612.USD","SG9999002562.SGD","02269","LU3063872942.SGD","LU0856984785.SGD"],"gpt_icon":0},{"id":"2602553587","title":"凯莱英遭Schroders PLC减持26.05万股 每股作价约82.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602553587","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602553587?lang=zh_cn&edition=full","pubTime":"2026-01-11 16:29","pubTimestamp":1768120140,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，1月7日，Schroders PLC减持凯莱英（06821）26.05万股，每股作价82.7099港元，总金额约为2154.59万港元。减持后最新持股数目为574.18万股，最新持股比例为20.84%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-11/doc-inhfxmcp3825365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","06821","BK0239","002821","BK0132","LU1328615791.USD"],"gpt_icon":0},{"id":"2602378543","title":"Schroders PLC减持凯莱英(06821)26.05万股 每股作价约82.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602378543","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602378543?lang=zh_cn&edition=full","pubTime":"2026-01-09 19:30","pubTimestamp":1767958245,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，1月7日，Schroders PLC减持凯莱英(06821)26.05万股，每股作价82.7099港元，总金额约为2154.59万港元。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260109/20260109193119_38417.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260109/20260109193119_38417.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1328615791.USD","BK0239","002821","BK1191","BK0132","06821"],"gpt_icon":0},{"id":"2601365109","title":"每日卖空追踪 | 凯莱英 01月08日卖空量成交1.77万股，卖空比例为4.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601365109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601365109?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861038,"startTime":"0","endTime":"0","summary":"凯莱英北京时间01月08日，跌1.25%，卖空量成交1.77万股，较上一交易日减少66.6%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108165117a4ab48b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108165117a4ab48b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","BK1191"],"gpt_icon":0},{"id":"2601508673","title":"中欧基金葛兰2025年三季度坚守医药板块，多只标的获增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2601508673","media":"财经杂谈","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601508673?lang=zh_cn&edition=full","pubTime":"2026-01-08 11:05","pubTimestamp":1767841535,"startTime":"0","endTime":"0","summary":"随着公募基金2025年三季度报披露完毕，中欧基金葛兰的投资布局与调仓动向受到市场广泛关注。从整体业绩来看，三季度期间，葛兰旗下三只基金均大幅跑赢同期业绩比较基准。信立泰首次出现在中欧医疗创新前十大重仓股名单中，该个股此前二季度期间位于其隐形重仓股行列。对于行业前景与投资布局，葛兰在三季报中指出，医药行业的长期发展核心驱动力依然在于创新升级、消费复苏及国产化替代。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108120245a7014cd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108120245a7014cd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","09939","BK1161","BK1191","06821","BK1515","BK1574"],"gpt_icon":0},{"id":"2601876792","title":"凯莱英H股午后涨幅扩大 机构普遍看好创新药产业链的长期机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2601876792","media":"上证快讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601876792?lang=zh_cn&edition=full","pubTime":"2026-01-07 14:04","pubTimestamp":1767765869,"startTime":"0","endTime":"0","summary":"1月7日午后，凯莱英H股涨幅扩大，盘中一度涨至84.65港元/股。截至13时15分，凯莱英报83.05港元/股，涨7.37%，成交额约8265万港元。同时，凯莱英A股延续涨势。消息面上，多家机构看好创新药产业链长期机会。太平洋证券的研报显示，2026年创新药产业链景气度持续提升；海通证券研报显示，该机构看好创新药产业链长期机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107140609a4a65027&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107140609a4a65027&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1191","06978","06821","BK1574"],"gpt_icon":0},{"id":"2601760808","title":"港股创新药ETF基金涨近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601760808","media":"云掌财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601760808?lang=zh_cn&edition=full","pubTime":"2026-01-07 13:58","pubTimestamp":1767765495,"startTime":"0","endTime":"0","summary":"盘面上，港股创新药表现活跃，凯莱英飙涨7%，泰格医药、昭衍新药、康方生物涨超5%，和黄医药、翰森制药、恒瑞医药等个股涨超4%。截至10：34，热门ETF——港股创新药ETF基金上涨2.85%，冲击三连涨！数据显示，港股创新药ETF基金近60日“吸金”超1亿；最新基金规模达9.39亿元。港股创新药ETF基金跟踪中证港股通创新药指数，指数编制方式更科学合理，成分股涵盖如百济神州、信达生物和药明生物等领军企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107135820a4a649a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107135820a4a649a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","03692","01801","06978","02269","00013","02315","BK1574","06821","BK1191","01276","06127","09926"],"gpt_icon":0},{"id":"2601828162","title":"港股异动 | CRO概念股集体走高 行业内外需共振 2026年业绩有望进入改善周期","url":"https://stock-news.laohu8.com/highlight/detail?id=2601828162","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601828162?lang=zh_cn&edition=full","pubTime":"2026-01-07 10:41","pubTimestamp":1767753707,"startTime":"0","endTime":"0","summary":"中泰证券认为，CRO、CDMO行业内外需共振，供给端逐步出清。兴业证券指出，受益于创新药BD出海和融资企稳回升，多家CRO新签订单逐季度加速，项目量实现双位数增长。Q4以来从实验用猴、安评报价到临床项目价格均有提升趋势，客户需求保持旺盛，展望2026年CRO业绩有望进入改善周期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389674.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03759","03347","LU0708995583.HKD","LU2045819591.USD","BK1191","LU0052750758.USD","LU2125910500.SGD","06821","BK1576","BK1583","LU0320764599.SGD","LU1046422090.SGD","LU2242644610.SGD","06127","BK1141","02359"],"gpt_icon":0},{"id":"2601880356","title":"凯莱英（002821）披露证券变动月报表，1月5日股价上涨3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601880356","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601880356?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:45","pubTimestamp":1767624323,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，凯莱英报收于95.88元，较前一交易日上涨3.17%，最新总市值为345.74亿元。该股当日开盘93.2元，最高96.88元，最低93.04元，成交额达5.58亿元，换手率为1.84%。近日，凯莱英发布H股证券变动月报表公告。公告显示，截至2025年12月31日，公司H股和A股的法定/注册股本均无变动。H股已发行股份为27,553,260股，A股已发行股份为331,889,160股，库存股为1,151,300股。H股限制性股票计划项下本月底可能发行的股份为1,465,000股。公司呈交日期为2026年1月5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1191","002821","06821","161027","BK0132","LU1328615791.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.asymchem.com","stockEarnings":[{"period":"1week","weight":-0.0591},{"period":"1month","weight":0.1018},{"period":"3month","weight":-0.0786},{"period":"6month","weight":-0.22},{"period":"1year","weight":0.804},{"period":"ytd","weight":0.1854}],"compareEarnings":[{"period":"1week","weight":-0.0109},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.018},{"period":"6month","weight":0.0489},{"period":"1year","weight":0.3464},{"period":"ytd","weight":0.039}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"凯莱英医药集团（天津）股份有限公司是一家主要从事提供医药外包一站式综合服务的中国公司。该公司的业务包括小分子药物定制研发生产（CDMO）、化学大分子CDMO、临床研究服务、制剂CDMO、生物大分子CDMO、技术输出和合成生物技术。该公司的产品类别涵盖多肽、寡核苷酸、单克隆抗体、抗体偶联药物和信使RNA等。该公司主要在国内外市场开展其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.050159},{"month":2,"riseRate":0.5,"avgChangeRate":0.017674},{"month":3,"riseRate":0.25,"avgChangeRate":-0.034311},{"month":4,"riseRate":0.5,"avgChangeRate":-0.084779},{"month":5,"riseRate":0.5,"avgChangeRate":0.040294},{"month":6,"riseRate":0.5,"avgChangeRate":0.01751},{"month":7,"riseRate":0.5,"avgChangeRate":0.064856},{"month":8,"riseRate":0.25,"avgChangeRate":-0.064097},{"month":9,"riseRate":0.75,"avgChangeRate":0.16322},{"month":10,"riseRate":0,"avgChangeRate":-0.125554},{"month":11,"riseRate":0.5,"avgChangeRate":0.010602},{"month":12,"riseRate":0.25,"avgChangeRate":-0.010177}],"exchange":"SEHK","name":"凯莱英","nameEN":"ASYMCHEM"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,06821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(06821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(06821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}